LuciTram 2mg is a targeted therapy used to treat melanoma
and other cancers associated with BRAF gene mutations. It is often used in
combination with other anticancer medicines to enhance effectiveness. This
medicine is widely prescribed in oncology practices across the United Kingdom,
United States, Australia, Singapore and Philippines. LuciTram helps slow tumor
growth and improves survival outcomes by targeting specific molecular pathways
involved in cancer progression.
Active Ingredient
Trametinib is a MEK inhibitor that blocks the MEK enzymes involved in cell
division and tumor growth. It belongs to a class of targeted therapies designed
to interfere with cancer cell signaling pathways.
Uses of LuciTram 2mg
• Treatment of melanoma
• Management of BRAF mutated cancers
• Relief from tumor progression
• Support for combination cancer therapy
How LuciTram 2mg Works
Trametinib works by inhibiting MEK1 and MEK2 enzymes in the MAPK pathway. This
pathway plays a crucial role in cancer cell division and survival. By blocking
this signaling cascade, it reduces tumor growth and spread.
How to Use LuciTram 2mg
- Take
once daily as prescribed
- Consume
on an empty stomach
- Follow
consistent timing each day
Possible Side Effects
• Diarrhea
• Skin rash
• Fatigue
• Swelling
Precautions
• Monitor heart and eye health
• Avoid during pregnancy
• Inform doctor about other medications
Safety Information
Use LuciTram only under medical supervision. Regular tests are required to
ensure safety and effectiveness. Do not stop medication without consulting your
doctor.
Storage
• Store in refrigerator if required
• Keep away from light
• Keep out of reach of children